Forest Ray

Bone marrow cells called megakaryocytes produce platelets with transcriptional programs that enhance antibody response times to several vaccines.

The nonprofit behind the work aims to bring the test to market in the next 18 to 24 months and is in discussions with potential commercialization partners. 

Investments into research and training of scientists in Africa are paying off with the growth of local genomics enterprises, but wages and job opportunities are not keeping pace.

The company plans pilot studies with several private insurers to support coverage for its suite of combined clinical and polygenic risk tests.

The company plans pilot studies with several private insurers to support coverage for its suite of combined clinical and polygenic risk tests.

A cross-ancestry polygenic risk score that incorporates the Tyrer-Cuzick model improved risk estimation in a retrospective study.

A Wistar Institute team found that two hypomorphic p53 variants in separate domains of that gene generate a shared gene expression signature in certain African populations.

The company is developing a nonsurgical approach to help increase testing rates and lower the time to diagnosis for endometriosis.

Researchers scanned cancer-related pathways in DNA repair disorders with high cancer prevalence as a means to search for new biomarkers and therapeutic targets.

The researchers also evaluated the performance of the risk scores, which encompass 28 diseases and 25 quantitative traits, using a benchmarking software tool.